^
Association details:
Biomarker:No biomarker
Cancer:Non-Hodgkin’s Lymphoma
Regimen:SMILE
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
Source:
Published date:
01/05/2023
Excerpt:
Extranodal NK/T-Cell Lymphomas....INDUCTION THERAPY...Preferred regimens...Modified SMILE (steroid [dexamethasone], methotrexate, ifosfamide, pegaspargase, and etoposide) x 4–6 cycles for advanced stage.